About
CRG is a market pioneer and innovator in healthcare investing that focuses on intellectual property investments in FDA-approved biopharmaceutical assets through royalty bonds, structured debt, revenue interests, and traditional royalty monetizations. The company targets investments between $20 and $200 million and works directly with leading healthcare companies, research institutions, and inventors to provide customized financing structures to meet their unique needs. Its financings are an attractive alternative to costly equity financings and restrictive debt financings. CRG helps healthcare organizations fund pipeline development, make acquisitions, and expand into new markets—all with an adaptable source of capital. Capital Royalty strives to help biopharma companies access capital that has little to no dilution. While much of the capital that we invest allows our counterparties to fund innovative research and development products, our primary source of collateral is derived from
Position in the VCSift Database
- • 33,888 investors in VCSift focus on the fintech sector.
- • 801 investors are based in Houston, Texas, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- fintech healthtech
- Location
- Houston, US
Contact Information
Find more investors like CRG
Search Investors